Irene de la Parra

ORCID: 0000-0002-4064-9133
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Bladder and Urothelial Cancer Treatments
  • Cancer Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Prostate Cancer Diagnosis and Treatment
  • Renal and related cancers
  • Prostate Cancer Treatment and Research
  • Renal and Vascular Pathologies
  • Ureteral procedures and complications
  • Radiomics and Machine Learning in Medical Imaging
  • Pituitary Gland Disorders and Treatments
  • Hormonal Regulation and Hypertension
  • Pediatric Urology and Nephrology Studies
  • Adrenal and Paraganglionic Tumors
  • Health Systems, Economic Evaluations, Quality of Life
  • Cutaneous Melanoma Detection and Management

Hospital Clínico San Carlos
2021-2024

Universidad Complutense de Madrid
2024

Background and Objectives: Prostate cancer (PCa) is a common disease with significant amount of patients first diagnose locoregional or distant metastases. This why it essential to have imaging tests sufficient sensitivity specificity. Having traditional methods recognized limitations, PET-PSMA born as weapon revolutionize the management PCa. Material Methods: We made comprehensive literature review from August October 2023 using databases also key clinical guidelines topic, focusing on...

10.20944/preprints202504.0326.v1 preprint EN 2025-04-04

Over the last three decades, European Randomized Study of Screening for Prostate Cancer (ERSPC) and US-based Prostate, Lung, Colorectal Ovarian (PLCO) have steered conversation around early detection prostate cancer. These two randomized trials assessed effect screening on cancer disease-specific mortality. Elevated PSA levels were followed by a systematic sextant biopsy. Standard repeat testing intervals applied. After controversies from 2009 to 2016 due contradicting results trials,...

10.3390/jpm13121677 article EN Journal of Personalized Medicine 2023-12-01

Since overdiagnosis and overtreatment pose significant risks in managing prostate cancer (PCa), active surveillance (AS) is the most common treatment low-risk patients. However, there no general agreement yet on inclusion criteria required follow-up. Multiparametric magnetic resonance imaging (mpMRI) of was born as a useful device these patients both diagnosis follow-up, it widely used daily clinical practice. We reflect current evidence described literature topic, its results, our experience.

10.3389/fruro.2024.1329274 article EN cc-by Frontiers in Urology 2024-04-12

Aim: The growth in the incidence of small renal masses has led implementation laparoscopic partial nephrectomy to become technique choice. However, arterial clamping and secondary ischemia still mean a controversial issue due risk failure. Our objective is evaluate existing literature its relationship our experience. Methods: We performed retrospective study series over six years. analyzed different clinical, perioperative postoperative functional outcome variables compared between tumor...

10.20517/2574-1225.2024.01 article EN Mini-invasive Surgery 2024-08-26

Delayed palliative management (DPM) is an alternative for prostate cancer (PCa) patients with poor performance status, or those who received radical treatment but progressed and no longer meet the criteria curative treatment. PIONEER a large network of federated data analytic platforms in PCa that aims to improve its care through application big analytics. The objective this study was describe clinical baseline characteristics outcomes receiving DPM using data. Descriptive on from four...

10.5173/ceju.2024.83 article EN Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication 2024-01-01

Ureteral stenosis in renal transplant patients is a frequent urological complication that involves significant morbidity and may compromise graft function. Despite the common use of minimally invasive techniques, surgery continues to be definitive treatment for ureteral stenosis, pyeloureteral anastomosis an infrequent but effective technique management this pathology has been described as safe with low percentage complications.

10.5152/tud.2023.23105 article EN cc-by Urology Research and Practice 2023-12-01

Chromophobe renal cell carcinoma (ChRCC) accounts for 4-6% of RCC1. Most ChRCC have good prognosis, but sarcomatoid transformation implies poor prognosis factor2. Although RCC was initially described as an own histological entity3, despite the fact that its mechanism is not known, it nowadays recognized this histology represents a or dedifferentiation high-grade malignant neoplasia originating from any other subtype RCC2. with differentiation very rare, few reported cases and there no...

10.14744/ejmo.2021.47478 article EN Eurasian Journal of Medicine and Oncology 2022-01-01

Dear Editor, We have carefully read the response from Val-Bernal et al1 and we feel sorry for any inconvenience that may caused. The purpose of our work2 was to deepen in this rare histologic type renal tumor which is chromophobe cancer (ChRCC) with sarcomatoid differentiation, its mode presentation, imaging techniques, histopathological analysis, prognostic factors treatment. Since it a subject discussed literature but few patients described, as visual way simplify low incidence pathology,...

10.14744/ejmo.2022.11965 article EN Eurasian Journal of Medicine and Oncology 2022-01-01

e18674 Background: In 2019, we used the American Society of Clinical Oncology (ASCO) Quality Training Program (QTP) as an instrument to improve inclusion rate in clinical trials (CTs) for bladder cancer patients from 24% 2018 43,75% 2019. CTs play important role developing new treatments, expanding or refining treatments that are already available, and/or identifying behavioral changes can prolong lives subjects. Therefore, believe it is and society maintain despite COVID-19 pandemic....

10.1200/jco.2021.39.15_suppl.e18674 article EN Journal of Clinical Oncology 2021-05-20

Invasive ductal breast carcinoma (IDC) metastasizes to several organs, but it does not usually affect the adrenal glands. In our knowledge, cases described in literature are few. A 60-year-old woman diagnosed with carcinoma, was found have metachronous metastasis during follow-up. While treatment is unclear, laparoscopic adrenalectomy could be a option curative intention. patient, we decided transperitoneal adrenalectomy, favourable evolution after surgery.

10.36106/ijar/2714224 article EN Indian Journal Of Applied Research 2021-10-01
Coming Soon ...